CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Accelerated Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Accelerated Pharma Inc
15w155 81st St
Phone: (773) 517-0789p:773 517-0789 BURR RIDGE, IL  60527-7903  United States Fax: (845) 818-3588f:845 818-3588
On 8/23/2017, Accelerated Pharma Inc filed a Registration Withdrawal Request of its Form S-1 (File No. 333-214048) with the SEC.The Company requests the withdrawal of the registration statement because the Company has decided not to proceed with this underwritten offering.
Business Summary
Accelerated Pharma, Inc. is a United States-based clinical-stage pharmaceutical company. The Company's drug development strategy is based on individualized targeting of patients using genomics. It is engaged in developing anticancer drugs using genomic selection that identifies patient responses prior to treatment. Its product Picoplatin, is a platinum-based chemotherapy agent.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201912/31/2016YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer and Director MichaelFonstein
President, Chief Executive Officer, Director MichaelFonstein 54
Chief Financial Officer, Chief Strategic Officer and Secretary Randy S.Saluck
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Acceler Limited Liability Company
ACCP

General Information
Number of Employees: 7 (As of 12/31/2016)
Outstanding Shares: 4,231,460 (As of 9/30/2019)
Stock Exchange: NASD
Federal Tax Id: 472380751
Fax Number: (845) 818-3588


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024